Cargando…

Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report

BACKGROUND: Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri syndrome (PTCS), is characterized by the presence of signs and symptoms of raised intracranial pressure without evidence of any intracranial structural cause and with normal cerebrospinal fluid microscopy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Maffeis, Laura, Dilena, Robertino, Guez, Sophie, Menni, Francesca, Bana, Cristina, Osnaghi, Silvia, Carrabba, Giorgio, Marchisio, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320575/
https://www.ncbi.nlm.nih.gov/pubmed/30611233
http://dx.doi.org/10.1186/s12887-018-1371-9
_version_ 1783385249423556608
author Maffeis, Laura
Dilena, Robertino
Guez, Sophie
Menni, Francesca
Bana, Cristina
Osnaghi, Silvia
Carrabba, Giorgio
Marchisio, Paola
author_facet Maffeis, Laura
Dilena, Robertino
Guez, Sophie
Menni, Francesca
Bana, Cristina
Osnaghi, Silvia
Carrabba, Giorgio
Marchisio, Paola
author_sort Maffeis, Laura
collection PubMed
description BACKGROUND: Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri syndrome (PTCS), is characterized by the presence of signs and symptoms of raised intracranial pressure without evidence of any intracranial structural cause and with normal cerebrospinal fluid microscopy and biochemistry. Obesity, various systemic diseases and endocrine conditions, and a number of medications are known to be risk factors for PTCS. The medications commonly associated with PTCS are amiodarone, antibiotics, corticosteroids, cyclosporine, growth hormone, oral contraceptives, vitamin A analogues, lithium, phenytoin, NSAIDs, leuprolide acetate, and some neuroleptic drugs. In relation to antibiotics, quinolones may cause intracranial hypertension, and most reported cases of quinolone-induced intracranial hypertension were associated with nalidixic acid, ciprofloxacin, ofloxacin, or pefloxacin. Literature reports of levofloxacin-induced PTCS are rare. Some authors recently hypothesized that Mycoplasma pneumoniae may trigger PTCS. CASE PRESENTATION: We report on a 14-year-old overweight White Italian boy who suffered headache, diplopia, and severe bilateral papilloedema after a Mycoplasma pneumoniae infection, exacerbated on levofloxacin intake. A spontaneous improvement in headache and a reduction in diplopia was seen during hospitalisation. Oral acetazolamide therapy led to the regression of papilloedema in about five months. No permanent eye damage has been observed in our patient to date. CONCLUSIONS: PTCS pathophysiology may be multifactorial and its specific features and severity may be a consequence of both constitutional and acquired factors interacting synergistically. It may be useful for paediatricians to know that some antibiotics may have the potential to precipitate PTCS in patients who already have an increased CSF pressure due to a transitory imbalanced CSF circulation caused by infections such as Mycoplasma pneumoniae, with headache being the first and most sensitive, but also the least specific, symptom. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12887-018-1371-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6320575
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63205752019-01-08 Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report Maffeis, Laura Dilena, Robertino Guez, Sophie Menni, Francesca Bana, Cristina Osnaghi, Silvia Carrabba, Giorgio Marchisio, Paola BMC Pediatr Case Report BACKGROUND: Idiopathic intracranial hypertension (IIH), also known as pseudotumour cerebri syndrome (PTCS), is characterized by the presence of signs and symptoms of raised intracranial pressure without evidence of any intracranial structural cause and with normal cerebrospinal fluid microscopy and biochemistry. Obesity, various systemic diseases and endocrine conditions, and a number of medications are known to be risk factors for PTCS. The medications commonly associated with PTCS are amiodarone, antibiotics, corticosteroids, cyclosporine, growth hormone, oral contraceptives, vitamin A analogues, lithium, phenytoin, NSAIDs, leuprolide acetate, and some neuroleptic drugs. In relation to antibiotics, quinolones may cause intracranial hypertension, and most reported cases of quinolone-induced intracranial hypertension were associated with nalidixic acid, ciprofloxacin, ofloxacin, or pefloxacin. Literature reports of levofloxacin-induced PTCS are rare. Some authors recently hypothesized that Mycoplasma pneumoniae may trigger PTCS. CASE PRESENTATION: We report on a 14-year-old overweight White Italian boy who suffered headache, diplopia, and severe bilateral papilloedema after a Mycoplasma pneumoniae infection, exacerbated on levofloxacin intake. A spontaneous improvement in headache and a reduction in diplopia was seen during hospitalisation. Oral acetazolamide therapy led to the regression of papilloedema in about five months. No permanent eye damage has been observed in our patient to date. CONCLUSIONS: PTCS pathophysiology may be multifactorial and its specific features and severity may be a consequence of both constitutional and acquired factors interacting synergistically. It may be useful for paediatricians to know that some antibiotics may have the potential to precipitate PTCS in patients who already have an increased CSF pressure due to a transitory imbalanced CSF circulation caused by infections such as Mycoplasma pneumoniae, with headache being the first and most sensitive, but also the least specific, symptom. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12887-018-1371-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-01-05 /pmc/articles/PMC6320575/ /pubmed/30611233 http://dx.doi.org/10.1186/s12887-018-1371-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Maffeis, Laura
Dilena, Robertino
Guez, Sophie
Menni, Francesca
Bana, Cristina
Osnaghi, Silvia
Carrabba, Giorgio
Marchisio, Paola
Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title_full Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title_fullStr Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title_full_unstemmed Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title_short Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
title_sort pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320575/
https://www.ncbi.nlm.nih.gov/pubmed/30611233
http://dx.doi.org/10.1186/s12887-018-1371-9
work_keys_str_mv AT maffeislaura pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT dilenarobertino pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT guezsophie pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT mennifrancesca pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT banacristina pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT osnaghisilvia pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT carrabbagiorgio pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport
AT marchisiopaola pseudotumourcerebriassociatedwithmycoplasmapneumoniaeinfectionandtreatmentwithlevofloxacinacasereport